| ||
Mallinckrodt Announces Definitive Agreement to Acquire CNS Therapeutics, Inc. Moneylife Mallinckrodt, the Pharmaceuticals business of Covidien (NYSE: COV), has announced a definitive agreement to acquire CNS Therapeutics, Inc., a privately held specialty pharmaceutical company focused on developing and commercializing products for ... See all stories on this topic » | ||
Pharmaceuticals Wholesaling in Australia Industry Market Research Report Now ... RedOrbit Pharmaceuticals Wholesaling industry growth rates have slowed in line with changes to the industry's operating environment and slower growth in the Pharmaceutical Benefits Scheme. The Pharmaceuticals Wholesaling industry has also been influenced by ... See all stories on this topic » | ||
| ||
Aerocrine: Aerocrine signs distribution agreement with third largest chinese ... The Herald | HeraldOnline.com Aerocrine AB (STO:AERO-B) today announces the signing of an import and distribution agreement with Shanghai Pharmaceuticals Holding Co., Ltd. (SPH) for Aerocrine's products for the Chinese market. SPH is the third largest pharmaceutical company in ... See all stories on this topic » | ||
Cedarburg Hauser Pharmaceuticals adds capacity at Grafton plant The Business Journal Cedarburg Hauser Pharmaceuticals has expanded the capacity of its Grafton active pharmaceutical ingredient (API) manufacturing plant to meet increased demand. The company said it will also implement upgrades to improve safety and its systems. See all stories on this topic » | ||
Diebold Streamlines AmerisourceBergen® Technology Group's Service Delivery IT News Online 25, 2012 /PRNewswire/ -- Looking to simplify its customer service operations, AmerisourceBergen® Technology Group (ABTG) has consolidated the delivery of its pharmaceutical equipment management services to Diebold, Incorporated (NYSE: DBD). See all stories on this topic » | ||
PropThink: China-centric SciClone is Creating Growth, Driven by Operating ... Reuters Three years ago SciClone, which is based in the U.S,, eliminated its in-house development program and began selling only partnered and in-licensed products as a China-focused pharmaceutical. In a PropThink exclusive interview, SciClone's CEO ... See all stories on this topic » | ||
Lawmakers, pharmaceutical sales companies call on administration to ... MedReps Lawmakers and industry officials, including medical device, biotech and pharmaceutical sales companies, are asking the Obama Administration to implement long-awaited provisions in the Sunshine Act, a bipartisan effort that will disclose payments to ... See all stories on this topic » | ||
Valeant Pharmaceuticals buys eye drug Visudyne from Vancouver's QLT Montreal Gazette Valeant Pharmaceuticals International Inc., soon to have its global headquarters in Montreal, has bought the well-known eye drug Visudyne from Vancouver's QLT Inc. for $112.5 million. The product will be added to Valeant's ophthalmology division ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment